Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries
D'Atri, F., Arthur, J., Blix, H.S., Hicks, L.A., Plachouras, D., Monnet, D.L., The European Survey On Transatlantic Task Force On Antimicrobial Resistance Tatfar Action Group
Rapid risk assessment: Risk related to the use of ‘do-it-yourself' CRISPR-associated gene engineering kit contaminated with pathogenic bacteria
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
US CDC report on antibiotic resistance threats in the United States, 2013
Antimicrobial resistance represent a serious threat to public health and patient safety and is a worldwide problem. Each year, in the European Union (EU) at least 25 000 patients die of infections with multidrug-resistant bacteria.
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and AustraliaArchived
While the discovery of antibiotics revolutionised the way we treat patients with bacterial infections, bacteria have become increasingly resistant to antibiotics, mostly due to the misuse of these medicines.
The Transatlantic Taskforce on Antimicrobial Resistance publishes its recommendations for collaboration in the global fight against antimicrobial resistanceArchived
In response to antimicrobial resistance and to strengthened transatlantic cooperation as agreed during the 2009 EU and US Summit, the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) published its report today, including a set of 17 recommendations in three key areas for future cooperation in the global fight to keep antimicrobials effective.